Cadence Solutions builds Clinical Intelligence that monitors patients with chronic disease, surfaces risks, and coordinates actions through supervised AI agents integrated into health systems' EMRs and workflows. The company works alongside more than 20 leading health systems and currently treats over 100,000 active patients. Peer-reviewed studies and real-world deployments cited in the company's materials show validated outcomes, including a 230% increase in heart-failure patients on guideline-directed medical therapy, a 70% relative increase in blood-pressure control for hypertension patients, a 27% reduction in hospital admissions, and a $1,302 per-patient annual reduction in total cost of care. Cadence reported it saves Medicare roughly $2.7 million every week and that its model returns more than $3 to Medicare for every dollar spent. Commercial traction includes tripling annual recurring revenue in 2025 and new affiliations with Duke Health and Texas Health Resources. With the Series C capital, Cadence plans to accelerate expansion into additional health systems, further develop its AI agents, and scale value-based care deployments.

Total raised

$241M

Funding rounds

3

Latest round

Series C

Latest activity

Jun 2026